Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07411352

Left Lateral Position vs Supine Position to Reduce Active Labor Duration

This randomized clinical trial aims to compare the effect of the left lateral decubitus position versus the supine position on the duration of the active phase of labor in nulliparous women. A total of 188 participants will be randomly assigned to one of two groups. The intervention group will be placed in the left lateral decubitus position, while the control group will remain in the supine position. Both positions will be maintained for 30-minute intervals with 5-minute rest periods, continuing until delivery. The primary outcome is the duration of the active phase of labor. Secondary outcomes include rates of cesarean section, use of oxytocin and analgesics, and maternal and neonatal complications.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Escuela

Tegucigalpa, Francisco Morazán Department, 11101, Honduras

Location status: Recruiting

Location contact

Adriana P Mendoza Batres, MD

PRINCIPAL_INVESTIGATOR

Juan J Galeas Reyes, MD

SUB_INVESTIGATOR

Kevin O Ponce Rodriguez, MD

PRINCIPAL_INVESTIGATOR

Ricardo A Gutierrez Ramirez, MD, MSc.

CONTACT

[email protected]

50497546940

About this study

Globally, maternal positioning during labor is a key component of humanized childbirth. While the World Health Organization recommends allowing women to adopt comfortable positions, the supine position remains prevalent in many clinical settings for practitioner convenience. This study in Honduras seeks to generate local evidence on the impact of maternal position on labor progression. Nulliparous women at term (≥37 weeks) with a singleton pregnancy in cephalic presentation and in the active phase of labor (≥6 cm dilation) will be recruited from the labor and delivery unit of the Hospital Materno Infantil. After providing informed consent, participants will be randomized. The primary efficacy endpoint is the time from the onset of the active phase (or intervention start, if later) until delivery. The study hypothesizes that the left lateral position will significantly reduce active labor duration compared to the supine position, potentially reducing unnecessary surgical interventions and improving the childbirth experience.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed and dated informed consent form.
  • Nulliparous woman.
  • Singleton pregnancy at ≥37 weeks of gestation.
  • Intact amniotic membranes.
  • Cephalic presentation.
  • In the active phase of labor (cervical dilation ≥6 cm).
  • Age ≥18 years.
  • No contraindication for vaginal delivery.
  • Possession of a mobile phone (for potential follow-up contact).

Exclusion criteria

  • Previous uterine surgery.
  • Maternal condition preventing vaginal delivery.
  • Fetal anomaly.
  • Premature rupture of membranes.
  • Multiple pregnancy.
  • Fetal demise.
  • Uterine myomas.
  • Maternal comorbidities (e.g., chronic hypertension, diabetes mellitus type -1/2/gestational, hypothyroidism).
  • Anemia.
  • Age <18 years.
  • Preterm gestation (<37 weeks).

Treatment and study plan

Left Lateral Decubitus Group

Other

Participants will be placed in the left lateral decubitus position for periods of 30 minutes, interspersed with 5-minute rest periods. This cycle will continue throughout the active phase of labor until delivery.

Supine Position Group

Other

Participants will remain in the supine position for periods of 30 minutes, interspersed with 5-minute rest periods. This cycle will continue throughout the active phase of labor until delivery.

Primary outcomes

  1. Duration of the active phase of labor.

    Time frame: Time (in minutes) from the diagnosis of the active phase of labor (cervical dilation ≥6 cm) to delivery of the newborn. Within the first 24 hours after diagnosis of active phase.

    The primary objective is to measure and compare the time taken to progress from the active phase to delivery between the two positioning groups.

Secondary outcomes

  1. Incidence of Cesarean Delivery

    Time frame: From randomization until delivery (anticipated within 48 hours per participant).

    The proportion of participants in each group who undergo a cesarean section.

  2. Use of Oxytocin for labor augmentation/conduction.

    Time frame: From randomization until delivery.

    The proportion of participants in each group who receive oxytocin infusion.

  3. Incidence of maternal complications (e.g., perineal tears, hemorrhage, hypotension).

    Time frame: From randomization until hospital discharge (approximately 24-48 hours postpartum).

    Composite of adverse maternal outcomes recorded during labor and the immediate postpartum period.

  4. Neonatal status as measured by Apgar score.

    Time frame: At 1 minute and 5 minutes after birth.

    The Apgar score (0-10) will be recorded and compared between groups.

Study contacts

Contact information is provided by the study sponsor or research team.

Ricardo A. Gutierrez Ramirez, MD, MSc

CONTACT

[email protected]

+50497546940

Sponsors and collaborators

Lead sponsor

Universidad Nacional Autonoma de Honduras

Other

Registry information

Official study title

Left Lateral Position Versus Supine Position in Reducing the Duration of the Active Phase of Labor: A Randomized, Single-Blind Clinical Trial

Acronym: DLI-SP

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 13, 2026
Registry last updated
Feb 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.